BUĞDAY, İ. Et Al. 2024. Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer. Anti-Cancer Drugs .

BUĞDAY, İ., İNANÇ, M., ÖZKAN, M., BOZKURT, O., COŞAR, R., FIRAT, S. T., ... MUTLU, E.(2024). Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer. Anti-Cancer Drugs .

BUĞDAY, İRFAN Et Al. "Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer," Anti-Cancer Drugs , 2024

BUĞDAY, İRFAN Et Al. "Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer." Anti-Cancer Drugs , 2024

BUĞDAY, İ. Et Al. (2024) . "Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer." Anti-Cancer Drugs .

@article{article, author={İRFAN BUĞDAY Et Al. }, title={Prognostic impact of elevated C-reactive protein and procalcitonin in patients with extensive-stage small cell lung cancer}, journal={Anti-Cancer Drugs}, year=2024}